QIAGEN NV (QGEN)
44.79
-0.86
(-1.88%)
USD |
NYSE |
Oct 07, 16:00
44.81
+0.02
(+0.04%)
Pre-Market: 20:00
QIAGEN EPS Diluted (Quarterly) : 0.4975 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4975 |
| March 31, 2026 | 0.3257 |
| December 31, 2025 | 0.519 |
| September 30, 2025 | 0.6266 |
| June 30, 2025 | 0.4644 |
| March 31, 2025 | 0.4339 |
| December 31, 2024 | 0.4264 |
| September 30, 2024 | 0.4377 |
| June 30, 2024 | -0.8264 |
| March 31, 2024 | 0.3561 |
| December 31, 2023 | 0.4364 |
| September 30, 2023 | 0.3479 |
| June 30, 2023 | 0.3613 |
| March 31, 2023 | 0.3802 |
| December 31, 2022 | 0.3976 |
| September 30, 2022 | 0.3692 |
| June 30, 2022 | 0.4334 |
| March 31, 2022 | 0.6957 |
| December 31, 2021 | 0.5746 |
| September 30, 2021 | 0.5913 |
| June 30, 2021 | 0.538 |
| March 31, 2021 | 0.5734 |
| December 31, 2020 | 1.011 |
| September 30, 2020 | 0.0739 |
| June 30, 2020 | 0.3954 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1768 |
| December 31, 2019 | 0.2002 |
| September 30, 2019 | -0.7311 |
| June 30, 2019 | 0.1981 |
| March 31, 2019 | 0.1303 |
| December 31, 2018 | 0.2704 |
| September 30, 2018 | 0.2644 |
| June 30, 2018 | 0.165 |
| March 31, 2018 | 0.1443 |
| December 31, 2017 | -0.1955 |
| September 30, 2017 | 0.2326 |
| June 30, 2017 | 0.0619 |
| March 31, 2017 | 0.0825 |
| December 31, 2016 | 0.0428 |
| September 30, 2016 | 0.1499 |
| June 30, 2016 | 0.1043 |
| March 31, 2016 | 0.0811 |
| December 31, 2015 | 0.2232 |
| September 30, 2015 | 0.1499 |
| June 30, 2015 | 0.1178 |
| March 31, 2015 | 0.0856 |
| December 31, 2014 | 0.1192 |
| September 30, 2014 | 0.1499 |
| June 30, 2014 | 0.1499 |
| March 31, 2014 | 0.1071 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 4.679 |
| Illumina, Inc. | 1.353 |
| Agilent Technologies, Inc. | 1.279 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Waters Corp. | -1.385 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 103.40M |
| Revenue (Quarterly) | 535.04M |
| Total Expenses (Quarterly) | 431.64M |
| Enterprise Value | 10.10B |
| Gross Profit Margin (Quarterly) | 63.17% |
| Profit Margin (Quarterly) | 19.33% |
| Earnings Yield | 4.40% |
| Operating Earnings Yield | 5.55% |
| Normalized Earnings Yield | 4.959 |